Brief: Sernova Announces Advancements With Its Novel Cell Pouch System
30/01/2023 12:46
Jan 30 (Reuters) - Sernova Corp SVA.TO :
* SERNOVA ANNOUNCES ADVANCEMENTS WITH ITS NOVEL CELL POUCH
SYSTEM™ TO PRESERVE THYROID FUNCTION FOLLOWING TOTAL
THYROIDECTOMY
* SERNOVA CORP-STUDY DEMONSTRATES THYROID
AUTO-TRANSPLANTATION
INTO CELL POUCH CAN RESTORE THYROID HORMONE PRODUCTION FOLLOWING
REMOVAL OF THYROID GLAND
* SERNOVA CORP - ENGAGED WITH REGULATORY AUTHORITIES TOWARDS
INITIATING CLINICAL DEVELOPMENT OF A PROSPECTIVE THERAPY FOR
HYPOTHYROIDISM
Source text for Eikon: ID:nGNX7DdDP9
Further company coverage: SVA.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sernova Biotherapeutics
See all newsBrief: Seraxis And Sernova Announce Appointment Of Former FDA Medical Officer Dr. Patricia Beaston As Chief Medical Officer Of Seraxis And Post Merger Betanova Biotherapeutics
Brief: Sernova Appoints Jonathan Rigby As Interim Chair
Brief: Sernova Biotherapeutics Provides Positive Interim Data From Ongoing Phase 1/2 Clinical Trial Of Cell Pouch Bio-Hybrid Organ In Patients Living With Type 1 Diabetes
Brief: Sernova Biotherapeutics Secures $4 Million Loan To Further Advance Its Clinical Development Plans
Brief: Sernova Biotherapeutics Inc Study Is On Track To Meet Key Clinical Trial Endpoints